Cognitive impairments following cranial irradiation can be mitigated by treatment with a tropomyosin receptor kinase B agonist.

MLA

Yang, Phillip, et al. “Cognitive Impairments Following Cranial Irradiation Can Be Mitigated by Treatment with a Tropomyosin Receptor Kinase B Agonist.” Experimental Neurology, vol. 279, May 2016, pp. 178–86. EBSCOhost, https://doi.org/10.1016/j.expneurol.2016.02.021.

APA

Yang, P., Leu, D., Ye, K., Srinivasan, C., Fike, J. R., & Huang, T.-T. (2016). Cognitive impairments following cranial irradiation can be mitigated by treatment with a tropomyosin receptor kinase B agonist. Experimental Neurology, 279, 178–186. https://doi.org/10.1016/j.expneurol.2016.02.021

Chicago

Yang, Phillip, David Leu, Keqiang Ye, Chandra Srinivasan, John R Fike, and Ting-Ting Huang. 2016. “Cognitive Impairments Following Cranial Irradiation Can Be Mitigated by Treatment with a Tropomyosin Receptor Kinase B Agonist.” Experimental Neurology 279 (May): 178–86. doi:10.1016/j.expneurol.2016.02.021.